Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PGE(2) receptor subtype functionality on immature forms of human leukemic blasts.

Emilie Malissein1, Stéphane Reynaud, Dominique Bordessoule

  • 1Laboratoire d'Homéostasie Cellulaire et Pathologie, Faculté de Médecine, Limoges, France.

Leukemia Research
|February 8, 2006
PubMed
Summary

Prostaglandin E2 (PGE2) regulates immune cells via EP receptors. This study found functional EP2 receptors on acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) blast cells, suggesting a new therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same author

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Blood cancer journal·2026
Same author

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

Blood·2026
Same author

Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.

Bone marrow transplantation·2026
Same author

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.

Bone marrow transplantation·2026

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Prostaglandin E2 (PGE2) is a key regulator of immune responses.
  • PGE2 exerts its effects through four distinct membrane receptors: EP1, EP2, EP3, and EP4.
  • The role of EP receptors in leukemia blast cells remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and functionality of EP receptors on immature blast cells from acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) patients.
  • To determine the specific EP receptor subtype(s) involved in mediating PGE2 effects on these leukemic cells.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) to detect EP receptor transcripts.
  • Western blot analysis to confirm protein expression of EP receptors.

Related Experiment Videos

  • Functional assays, including cAMP production and calcium flux, to assess receptor activity.

    • Main Results:

    • RT-PCR confirmed the presence of all four EP receptor subtype transcripts (EP1-4) in AML (M0, M1, M2 subtypes) and ALL blast cells.
    • Western blot analysis and functional assays demonstrated the presence of functional EP2 receptors.
    • PGE2 influences blast cell physiology primarily through the EP2 receptor, leading to a cAMP-elevating effect.

    Conclusions:

    • Immature AML and ALL blast cells express functional EP2 receptors.
    • PGE2 signaling via EP2 receptors, mediated by cAMP, represents a potential mechanism influencing leukemia blast cell physiology.
    • Further investigation is warranted to extend these findings to more differentiated leukemic phenotypes.